Loading company financials…
NASDAQ NMS - GLOBAL MARKET · Life Sciences Tools & Services · CIK 0001110803
$282.86
+5.57% · delayed ~15 min
Last price from Oct 21, 2026
$43.28B market value
From ILLUMINA, INC.'s FY2025 10-K, filed Feb 12, 2026 · read the filing
ILLUMINA makes measuring and control instruments. It took in $4.34B last year, which makes it a mid-sized company. Of every dollar it sells, about 20 cents is left as profit.
The financial picture is led by profitability, with debt worth watching, while growth remain weak.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
Recent open-market selling by 3 insiders, not under a pre-arranged plan.
$288.0M sold in the last 120 days · Read the filing
These are things the company filed or that a published model flagged — not predictions, and not a reason on their own to buy or sell anything.
Financial health
A mixed picture — some clear strengths and some weaknesses.
From ILLUMINA, INC.'s FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Operating income
-$833.0M → $807.0M
Profit
-$1.22B → $850.0M
Operating margin
-19.1% → 18.6%
Profit margin
-28.0% → 19.6%
Measured against FY2024, from the 10-K filed Feb 12, 2026
Improved: turned positive
-$833.0M to $807.0MCritical
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: turned positive
-$1.22B to $850.0MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
How the latest move compares (quote delayed ~15 min), and what was published around it
ILMN rose 5.57% on the latest quote. The average Technology company tracked here moved −1.27%, and the S&P 500 −1.04%. That is 6.8 points above its sector and 6.6 points above the market.
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
The growth rate someone buying today is paying for, against what the company has delivered
At today's price, the market is paying for free cash flow to grow by about 16% a year for the next 10 years. Over the last 12 years it grew by about 10% a year.
The essentials
Each answered from the filings, with the numbers behind it.
Yes. It keeps about 20 cents of every dollar of sales as profit, earning $850.0M last year.
No. Sales shrank 0.7% last year.
Manageable. For every $1 it owes, it owns $1.69 in assets.
Core operating and valuation reference metrics
Income
This company pays no dividend. It keeps its profits and reinvests them in the business instead, so any return would have to come from the share price.
Figures from the FY2025 annual filing
Last year it earned $850.0M and generated $1.08B of cash from operations.
Reported annual figures
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Feb 12, 2026Filing for FY2025 | FY202410-K · Feb 12, 2025Filing for FY2024 | FY202310-K · Feb 16, 2024Filing for FY2023 | FY202210-K · Feb 17, 2023Filing for FY2022 | FY202110-K · Feb 17, 2023Filing for FY2021 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $4.34B | $4.37B | $4.50B | $4.53B | $3.24B | −0.7% |
| Cost of revenue | $1.47B | $1.51B | $1.76B | $1.37B | $1.04B | −2.5% |
| Gross profit | $2.87B | $2.86B | $2.74B | $3.15B | $2.20B | +0.3% |
| Gross marginGross profit ÷ revenueWhat is this? | 66.1% | 65.4% | 60.9% | 69.7% | 68.0% | +0.6 pts |
| Selling, general and administrative | $1.09B | $1.09B | $1.61B | $2.09B | $941.0M | −0.5% |
| Operating income | $807.0M | -$833.0M | -$1.07B | -$123.0M | $580.0M | n/m |
| Operating marginOperating income ÷ revenueWhat is this? | 18.6% | -19.1% | -23.7% | -2.7% | 17.9% | +37.6 pts |
| Interest expense | $101.0M | $100.0M | $77.0M | $61.0M | $49.0M | +1.0% |
| Income before tax | $1.09B | -$1.18B | -$1.12B | $884.0M | $856.0M | n/m |
| Net income | $850.0M | -$1.22B | -$1.16B | $762.0M | $656.0M | n/m |
| Net marginNet income ÷ revenueWhat is this? | 19.6% | -28.0% | -25.8% | 16.8% | 20.3% | +47.5 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $5.56 | $-7.69 | $-7.30 | $4.85 | $4.49 | n/m |
† calculated from other reported figures, such as total liabilities as assets minus equity.
This company's latest filing beside its peers' stored scores
| Company | Health | F-Score | Revenue growth | Profit margin | P/E | Debt to equity |
|---|---|---|---|---|---|---|
| ILMNILLUMINA, INC. · this page | 6.0/10 | 7/8 |
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Officers, directors and major shareholders must report within two business days of a trade.
Had shares withheld to cover taxes — 1,303 shares at $293.69 ($382.7K)
Holds 107,770 shares after this filing.
Was granted or awarded shares — 113 shares at $219.80 ($24.8K)
Holds 11,143 shares after this filing.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Signed a material agreement · Took on a direct financial obligation
Read the filingReported another event
Read the filingWrite down why you are following ILLUMINA, INC., what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
The 45 subsidiaries named in its 10-K, incorporated across 33 places. A filer lists the significant ones and may leave the rest out, so this is the floor rather than the full count.
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from ILMN's 10-K for fiscal year 2025 (period ending 2025-12-28, filed Feb 12, 2026), reported under the US GAAP taxonomy. View the source filing. Total liabilities were not tagged directly and were calculated as assets minus equity.
3 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. Accounting had too few reported figures and is left out of the average rather than counted as a weakness, so a company is never marked down for a figure it did not publish. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 8 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 6.0 | 7/8 | 10-K, filed Feb 12, 2026 |
| FY2024 | 2.0 | 6/8 | 10-K, filed Feb 12, 2025 |
| FY2023 | 2.0 | 4/8 | 10-K, filed Feb 16, 2024 |
| FY2022 | 7.3 | 4/8 | 10-K, filed Feb 18, 2022 |
| FY2021 | 10.0 | 3/3 | 10-K, filed Feb 17, 2021 |
| FY2019 | 8.0 | 8/9 | 10-K, filed Feb 11, 2020 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
7 of 8 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's. One could not be evaluated and is excluded from the total rather than counted as a failure.
7.90
In the safe zone
For this model, above 2.99 is safe and below 1.81 is distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — This company has not reported enough of the required figures to calculate this score.
This company has not reported enough of the required figures to calculate this score.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Improved: +37.6 pts
-19.1% to 18.6%Critical
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Improved: +47.5 pts
-28.0% to 19.6%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Improved: turned positive
-$7.69 to $5.56Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +31.3%
$709.0M to $931.0MSignificant
Why it matters: Cash left after paying for the plant that produced it — the money genuinely available for dividends, buybacks or paying down debt. Harder to flatter than profit.
Improved: +25.8%
$1.13B to $1.42BSignificant
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Changed: +15.6%
$128.0M to $148.0MSignificant
Why it matters: Neither good nor bad on its own. Heavy spending is a company building capacity or a company struggling to stand still, and the two look identical in this figure.
Improved: -3.8%
159.0M to 153.0MNotable
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
Q2 FY2026 against Q2 FY2025, from the 10-Q filed Jul 31, 2026 — read it.
Deteriorated: −4.3 pts
22.2% to 17.9%Significant
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Improved: +9.4%
$1.06B to $1.16BNotable
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Improved: +10.8%
$695.0M to $770.0MNotable
Why it matters: What is left of sales after the direct cost of producing them. It normally moves with revenue, so a move out of step with revenue is the part worth noticing.
Improved: +14.5%
$214.0M to $245.0MNotable
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Deteriorated: -11.9%
$235.0M to $207.0MNotable
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Deteriorated: -8.4%
$1.50 to $1.37Notable
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +11.3%
$934.0M to $1.04BNotable
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: -3.8%
157.0M to 151.0MNotable
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
Q2 FY2026 against Q1 FY2026, from the 10-Q filed Jul 31, 2026 — read it. Quarter-to-quarter moves include seasonal swings — a retailer's holiday quarter — which the year-earlier comparison removes.
Improved: +54.5%
$134.0M to $207.0MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +56.5%
$0.88 to $1.37Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +17.2%
$209.0M to $245.0MSignificant
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: +5.6 pts
12.3% to 17.9%Significant
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Improved: +6.2%
$1.09B to $1.16BNotable
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Improved: +6.8%
$721.0M to $770.0MNotable
Why it matters: What is left of sales after the direct cost of producing them. It normally moves with revenue, so a move out of step with revenue is the part worth noticing.
Improved: +2.0 pts
19.2% to 21.1%Notable
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Improved: -1.3%
153.0M to 151.0MNotable
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
3 other measures barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Discounted at 8%–10% a year, with growth settling to 2.5% after 10 years. Those rates are ordinary choices, not measurements: across that range the assumed growth works out between 14% and 19%. This describes what the price implies — it is not a forecast, and not a view on whether the price is right.
Opinions from 28 analysts covering this company, as of . Their views, not this site's.
Of 28 analysts publishing on this company, 7 say strong buy, 9 say buy, 9 say hold, 2 say sell and 1 say strong sell. Analysts are paid to publish a view and are wrong often; the split above says how much they agree with each other, which is the part a single headline rating hides.
Published by Finnhub. Analyst coverage skews towards larger companies and towards optimism — sell ratings are rare across the whole market, so a company with none is ordinary rather than endorsed.
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 6.2% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
The trailing P/E is 52.5x — a high multiple relative to the current trailing profit.
This company has not reported enough of the required figures to calculate this score.
| -0.7% |
| 19.6% |
| 50.91x |
| 1.44x |
| TMOTHERMO FISHER SCIENTIFIC INC. | 7.3/10 | 6/8 | 3.9% | 15.0% | 38.07x | 1.07x |
|---|
| DHRDANAHER CORP /DE/ | 9.0/10 | 5/9 | 2.9% | 14.7% | 44.94x | 0.59x |
|---|
| AAGILENT TECHNOLOGIES, INC. | 9.0/10 | 6/9 | 6.7% | 18.8% | 37.77x | 0.89x |
|---|
| IQVIQVIA HOLDINGS INC. | 6.0/10 | 5/9 | 5.9% | 8.3% | 34.71x | 3.59x |
|---|
| WATWATERS CORP /DE/ | 9.0/10 | 6/9 | 7.0% | 20.3% | 42.22x | 0.98x |
|---|
| MTDMETTLER TOLEDO INTERNATIONAL INC/ | 8.7/10 | 7/9 | 4.0% | 21.6% | 39.46x | -158.08x |
|---|
| Median of peers | 8.8/10 | — | 4.9% | 16.9% | 38.77x | 0.94x |
|---|
Peers come from the company's industry classification. A difference describes the companies; it does not rank them.
Was granted or awarded shares — 107 shares at $219.80 ($23.5K)
Holds 6,887 shares after this filing.
Was granted or awarded shares — 4,549 shares
Holds 4,549 shares after this filing.
Was granted or awarded shares — 14,214 shares
Holds 18,763 shares after this filing.
Had shares withheld to cover taxes — 408 shares at $211.06 ($86.1K)
Holds 40,927 shares after this filing.
Sold on the open market — 57,488 shares at $213.20 ($12.3M)
Holds 976,422 shares after this filing.
Sold on the open market — 10,620 shares at $213.73 ($2.3M)
Holds 965,802 shares after this filing.
Sold on the open market — 8,439 shares at $215.20 ($1.8M)
Holds 957,363 shares after this filing.
Sold on the open market — 13,261 shares at $216.38 ($2.9M)
Holds 944,102 shares after this filing.
Sold on the open market — 14,196 shares at $217.29 ($3.1M)
Holds 929,906 shares after this filing.
Sold on the open market — 9,721 shares at $218.33 ($2.1M)
Holds 920,185 shares after this filing.
Sold on the open market — 13,717 shares at $219.41 ($3.0M)
Holds 906,468 shares after this filing.
Sold on the open market — 6,656 shares at $220.17 ($1.5M)
Holds 899,812 shares after this filing.
Sold on the open market — 9,961 shares at $221.55 ($2.2M)
Holds 889,851 shares after this filing.
Sold on the open market — 7,500 shares at $217.28 ($1.6M)
Holds 882,351 shares after this filing.
Sold on the open market — 100,650 shares at $218.39 ($22.0M)
Holds 781,701 shares after this filing.
Sold on the open market — 11,351 shares at $219.18 ($2.5M)
Holds 770,350 shares after this filing.
Sold on the open market — 92,776 shares at $225.26 ($20.9M)
Holds 1,317,075 shares after this filing.
Sold on the open market — 38,201 shares at $226.13 ($8.6M)
Holds 1,278,874 shares after this filing.
Sold on the open market — 42 shares at $226.79 ($9.5K)
Holds 1,278,832 shares after this filing.
Sold on the open market — 38,213 shares at $224.72 ($8.6M)
Holds 1,240,619 shares after this filing.
Sold on the open market — 53,123 shares at $225.69 ($12.0M)
Holds 1,187,496 shares after this filing.
Sold on the open market — 14,782 shares at $226.50 ($3.3M)
Holds 1,172,714 shares after this filing.
Sold on the open market — 425 shares at $227.22 ($96.6K)
Holds 1,172,289 shares after this filing.
Sold on the open market — 4,873 shares at $226.74 ($1.1M)
Holds 1,167,416 shares after this filing.
Sold on the open market — 54,309 shares at $227.67 ($12.4M)
Holds 1,113,107 shares after this filing.
Sold on the open market — 24,363 shares at $228.64 ($5.6M)
Holds 1,088,744 shares after this filing.
Sold on the open market — 16,990 shares at $229.72 ($3.9M)
Holds 1,071,754 shares after this filing.
Sold on the open market — 28,439 shares at $230.54 ($6.6M)
Holds 1,043,315 shares after this filing.
Sold on the open market — 9,405 shares at $231.23 ($2.2M)
Holds 1,033,910 shares after this filing.
Sold on the open market — 19,884 shares at $202.37 ($4.0M)
Holds 2,069,541 shares after this filing.
Sold on the open market — 57,544 shares at $203.16 ($11.7M)
Holds 2,011,997 shares after this filing.
Sold on the open market — 4,759 shares at $204.16 ($971.6K)
Holds 2,007,238 shares after this filing.
Sold on the open market — 12,813 shares at $205.00 ($2.6M)
Holds 1,994,425 shares after this filing.
Sold on the open market — 1,132 shares at $207.65 ($235.1K)
Holds 1,993,293 shares after this filing.
Sold on the open market — 3,563 shares at $208.55 ($743.1K)
Holds 1,989,730 shares after this filing.
Sold on the open market — 9,078 shares at $209.68 ($1.9M)
Holds 1,980,652 shares after this filing.
Sold on the open market — 23,638 shares at $210.66 ($5.0M)
Holds 1,957,014 shares after this filing.
Sold on the open market — 34,009 shares at $211.90 ($7.2M)
Holds 1,923,005 shares after this filing.
Sold on the open market — 29,805 shares at $212.83 ($6.3M)
Holds 1,893,200 shares after this filing.
Sold on the open market — 71,939 shares at $213.36 ($15.3M)
Holds 1,821,261 shares after this filing.
Sold on the open market — 42,218 shares at $214.57 ($9.1M)
Holds 1,779,043 shares after this filing.
Sold on the open market — 18,405 shares at $215.62 ($4.0M)
Holds 1,760,638 shares after this filing.
Sold on the open market — 15,263 shares at $216.88 ($3.3M)
Holds 1,745,375 shares after this filing.
Sold on the open market — 21,147 shares at $217.72 ($4.6M)
Holds 1,724,228 shares after this filing.
Sold on the open market — 5,693 shares at $218.46 ($1.2M)
Holds 1,718,535 shares after this filing.
Sold on the open market — 9,348 shares at $219.82 ($2.1M)
Holds 1,709,187 shares after this filing.
Sold on the open market — 4,528 shares at $210.45 ($952.9K)
Holds 1,704,659 shares after this filing.
Sold on the open market — 7,151 shares at $211.54 ($1.5M)
Holds 1,697,508 shares after this filing.
Sold on the open market — 13,050 shares at $212.65 ($2.8M)
Holds 1,684,458 shares after this filing.
Sold on the open market — 6,821 shares at $213.81 ($1.5M)
Holds 1,677,637 shares after this filing.
Sold on the open market — 13,668 shares at $214.64 ($2.9M)
Holds 1,663,969 shares after this filing.
Sold on the open market — 9,365 shares at $215.61 ($2.0M)
Holds 1,654,604 shares after this filing.
Sold on the open market — 12,602 shares at $216.44 ($2.7M)
Holds 1,642,002 shares after this filing.
Sold on the open market — 8,187 shares at $217.84 ($1.8M)
Holds 1,633,815 shares after this filing.
Sold on the open market — 86,825 shares at $218.60 ($19.0M)
Holds 1,546,990 shares after this filing.
Sold on the open market — 133,256 shares at $219.47 ($29.2M)
Holds 1,413,734 shares after this filing.
Sold on the open market — 3,883 shares at $220.13 ($854.8K)
Holds 1,409,851 shares after this filing.
Notice filed ahead of a planned sale — the sale itself has not necessarily happened yet.
Filed notice to sell 150,000 shares ($32.0M) on or after .
Shares originally obtained via Purchases of shares of Common Stock in the open market (2).
Filed notice to sell 200,000 shares ($45.0M) on or after .
Shares originally obtained via Purchases of shares of Common Stock in the open market (2).
Filed notice to sell 300,000 shares ($67.0M) on or after .
Shares originally obtained via Purchases of shares of Common Stock in the open market (2).
Filed notice to sell 250,000 shares ($53.3M) on or after .
Shares originally obtained via Purchases of shares of Common Stock in the open market (2).
Filed notice to sell 355,000 shares ($72.8M) on or after .
Shares originally obtained via Purchases of shares of Common Stock in the open market (2).
Filed notice to sell 1,033 shares ($199.5K) on or after .
Shares originally obtained via Restricted Stock Units.
Estimated from how often this has happened before, not a confirmed date.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Signed a material agreement · Terminated a material agreement · Took on a direct financial obligation
Reported another event
Read the filingReported another event
Read the filingQuarterly report for Q2 FY2026
Revenue +9.4% · Profit margin −4.3 pts · Gross profit +10.8% — against Q2 FY2025
Read the filingPublished results
Read the filingHad a director or senior officer leave or join
Read the filingHeld a shareholder vote
Read the filingQuarterly report for Q1 FY2026
Operating margin +3.4 pts · Operating income +27.4% · Free cash flow +20.7% — against Q1 FY2025
Read the filingPublished results · Reported another event
Read the filingProxy statement for a shareholder meeting
Read the filingHad a director or senior officer leave or join · Made a Regulation FD disclosure
Read the filingAnnual report for FY2025
Operating margin +37.6 pts · Operating income turned positive · Profit turned positive — against FY2024
Read the filingPublished results
Read the filingCompleted an acquisition or disposal · Reported another event
Read the filingPublished results
Read the filingHad a director or senior officer leave or join · Made a Regulation FD disclosure
Read the filingReported another event
Read the filingReported another event
Read the filingThe first 40 of 45. The rest are in the exhibit.
Source: Exhibit 21 of the 10-K filed 2026-02-12. These are legal entities, not brands or acquisitions — a company that bought a business may hold it inside an entity named here, or inside one small enough that the rule does not require naming it at all.
Coverage from the last 30 days
Twist Bioscience Sinks 9%, Illumina Down 5% as AI and Genomics Stocks Slide
Yahoo ·
Illumina (ILMN) Reports Next Week: Wall Street Expects Earnings Growth
Yahoo ·
ILMN Q3 Earnings Preview: Strong Clinical Demand May Lift Performance
Yahoo ·
Will HCA Healthcare's Q3 Earnings Benefit From Higher Admissions?
Yahoo ·
S&P 500 Top Movers: Oct. 21, 2026 US Session
ChartMill ·
S&P 500 Top Movers on Oct. 21, 2026: Supermicro Leads Gainers, Dexcom Leads Losers
ChartMill ·
How Long Can GeneDx Keep Burning Cash?
Yahoo ·
Stock Market Today: Nasdaq Vaults On SpaceX Report; Software Names Gain (Live Coverage)
Yahoo ·
Illumina’s (ILMN) Strong Quarterly Beats on Revenue and Earnings Drive Share Gains
Yahoo ·
Illumina BioInsight Platform expands with new software to accelerate the path from sequencing to discovery
Yahoo ·
SpaceX Jumps 10%, Nasdaq 100 Rises as AI Trade Returns: Stock Market Today
Benzinga ·
Can Higher Admissions Offset Rising Costs in UHS' Q3 Earnings?
Yahoo ·
Primary sources and further research